A fusogenic segment of glycoprotein H from herpes simplex virus enhances transfection efficiency of cationic liposomes

Journal of Gene Medicine

Volumn 10, Issue 6, 2008, Pages 646-654

  Tu, Ying ^a   Kim, Ji Seon ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cationic liposome; Endosomal release; Fusogenic peptide; Non viral gene delivery

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GLYCOPROTEIN; GLYCOPROTEIN H; LIPOSOME; LUCIFERASE;

ARTICLE; CELL ASSAY; CELL TRANSPORT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENZYME ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTERNALIZATION; NONVIRAL GENE DELIVERY SYSTEM; PH; PRIORITY JOURNAL; TRANSGENE; WILD TYPE;

CELL LINE; FLOW CYTOMETRY; GENE THERAPY; GLYCOSPHINGOLIPIDS; HUMANS; HYDROGEN-ION CONCENTRATION; LIPIDS; LIPOSOMES; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PROTEIN STRUCTURE, TERTIARY; TRANSFECTION; VIRAL ENVELOPE PROTEINS;

SIMPLEXVIRUS;

EID: 46649091525     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1184     Document Type: Article

References (31)

1. Riddle KW, Kong HJ, Leach JK, et al. Modifying the proliferative state of target cells to control DNA expression and identifying cell types transfected in vivo. Mol Ther 2007; 15: 361-368.
2. Li SD, Huang L. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther 2006; 13: 1313-1319.
3. Lechardeur D, Lukacs GL. Intracellular barriers to non-viral gene transfer. Curr Gene Ther 2002; 2: 183-194.
4. Lechardeur D, Verkman AS, Lukacs GL. Intracellular routing of plasmid DNA during non-viral gene transfer. Advanced Drug Deliv Rev 2005; 57: 755-767.
5. Kichler A, Mechtler K, Behr JP, et al. Influence of membrane-active peptides on lipospermine/DNA complex mediated gene transfer. Bioconjug Chem 1997; 8: 213-221.
6. Shigeta K, Kawakami S, Higuchi Y, et al. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells. J Control Release 2007; 118: 262-270.
7. Karmali PP, Chaudhuri A. Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises. Med Res Rev 2006.
8. Dass CR, Choong PF. Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof applicability. J Control Release 2006; 113: 155-163.
9. Safinya CR, Ewert K, Ahmad A, et al. Cationic liposome-DNA complexes: from liquid crystal science to gene delivery applications. Philos Trans 2006; 364: 2573-2596.
10. Simoes S, Filipe A, Faneca H, et al. Cationic liposomes for gene delivery. Expert Opinion Drug Deliv 2005; 2: 237-254.
11. Wrobel I, Collins D. Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim Biophys Acta 1995; 1235: 296-304.
12. Zabner J, Fasbender AJ, Moninger T, et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995; 270: 18997-19007.
13. Zhou X, Huang L. DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim Biophys Acta 1994; 1189: 195-203.
14. Simoes S, Slepushkin V, Pires P, et al. Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides. Gene Ther 1999; 6: 1798-1807.
15. Futaki S, Masui Y, Nakase I, et al. Unique features of a pH-sensitive fusogenic peptide that improves the transfection efficiency of cationic liposomes. J Gene Med 2005; 7: 1450-1458.
16. Simoes S, Slepushkin V, Gaspar R, et al. Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides. Gene Ther 1998; 5: 955-964.
17. +-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region. J Biol Chem 1996; 271: 13417-13421.
18. Delahunty MD, Rhee I, Freed EO, et al. Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: identification of critical glycine residues. Virology 1996; 218: 94-102.
19. Schaal H, Klein M, Gehrmann P, et al. Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion. J Virol 1995; 69: 3308-3314.
20. Parker AL, Collins L, Zhang X, et al. Exploration of peptide motifs for potent non-viral gene delivery highly selective for dividing cells. J Gene Med 2005; 7: 1545-1554.
21. Gianni T, Martelli PL, Casadio R, et al. The ectodomain of herpes simplex virus glycoprotein H contains a membrane alpha-helix with attributes of an internal fusion peptide, positionally conserved in the herpesviridae family. J Virol 2005; 79: 2931-2940.
22. Galdiero M, Whiteley A, Bruun B, et al. Site-directed and linker insertion mutagenesis of herpes simplex virus type 1 glycoprotein H. J Virol 1997; 71: 8.
23. Browne HM, Bruun BC, Minson AC. Characterization of herpes simplex virus type 1 recombinants with mutations in the cytoplasmic tail of glycoprotein H. J Gen Virol 1996; 77: 2569-2573.
24. Galdiero S, Falanga A, Vitiello M, et al. Fusogenic domains in herpes simplex virus type 1 glycoprotein H. J Biol Chem 2005; 280: 28632-28643.
25. Struck D, Hoekstra D, Pagano R. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 1981; 20: 4093-4099.
26. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
27. Smith P, Krohn R, Hermanson G, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85.
28. Earp LJ, Delos SE, Park HE, et al. The many mechanisms of viral membrane fusion proteins. Curr Top Microbiol Immunol 2005; 285: 25-66.
29. Peisajovich SG, Shai Y. Viral fusion proteins: multiple regions contribute to membrane fusion. Biochim Biophys Acta 2003; 1614: 122-129.
30. Peisajovich SG, Samuel O, Shai Y. Paramyxovirus F1 protein has two fusion peptides: implications for the mechanism of membrane fusion. J Mol Biol 2000; 296: 1353-1365.
31. Oliveira S, Rooy Iv, Kranenburg O, et al. Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes. Int J Pharm 2007; 331: 211-214.